Regnum Corp. (RGMP)

[Chuckles759]

So, If I understand this correctly....

80,000,000 Authorized
22,950,000 Shares Outstanding
22,680,000 Shares held by Phoenixus AG
-----------
270,000 Public Float

Then, from the 10-Q (30Sep21)

"On October 8, 2021, Regnum issued a convertible promissory note in the principal amount of $1,500,000 to its principal shareholder, Phoenixus to support clinical development and general expenses. The principal will bear interest at the rate of 3% per annum, payable on maturity or conversion. The note will mature 365 days following the date of issue, unless earlier repurchased or converted. Phoenixus has an option to convert the principal and interest into common shares of Regnum at $0.40 per share, upon Regnum completing an equity financing of at least an additional $5,000,000 in the aggregate."

That comes out to about 3,862,500 shares common due Oct 8, 2022. If this not is not settled before then, more shares common will need to be registered...then there will be about 26,812,500 S/O.

Small dillution...but it puts the current 1% available shares down to even less.

With the hopeful chance that the CytoDyn HIV BLA being approved in late 2022 and a PDUFA date in mid-2023, Regnum really doesn't have any cashflow for another year.

Is Phoenixus AG going to continue paying the bills? Think that $1.5M is going to get them through Oct 2022....when income from the CytoDyn HIV BLA probably won't be realized until at least mid-2023?

Oh, and how much and when are the milestone payments to CytoDyn due?

Trying to lay this out on a calendar and things aren't matching up.